BUY Honasa Consumer — IDBI Capital
byIDBI CapitalHorizon: 1–3 months22 Jun 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·25 Jun · 5d ago
Honasa Consumer Ltd has acquired a majority stake (58%) in Fluence Pharma, a science-backed nutraceuticals company. This strategic move marks Honasa's entry into the high-growth nutraceuticals market,
BSE · Company Update·23 Jun · 6d ago
Honasa Consumer Limited is entering the nutraceuticals market by acquiring a majority stake in Fluence Pharma.
NSE · Press Release·23 Jun · 6d ago
Honasa Consumer Ltd received approval for the acquisition of Fluence Pharma Private Limited and the incorporation of a wholly owned subsidiary.
BSE · Company Update·23 Jun · 6d ago
1 other SEBI-registered advisor has an active short-term BUY call on this stock
Advisor consensus · same horizon·11 Jun · 3w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.